Accuray Incorporated (ARAY) vs Context Therapeutics Inc. (CNTX)
A side-by-side comparison of Accuray Incorporated and Context Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARAY
Accuray Incorporated
$0.30HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CNTX
Context Therapeutics Inc.
$0.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ARAY vs CNTX
growth of $100 · dividends reinvested · last 5yARAY -92.4% (-40.3%/yr)CNTX -93.4% (-41.9%/yr)ARAY compounded faster over this window
ARAY CNTX
ARAY vs CNTX: by the numbers
- •ARAY is the larger company ($36M vs $31M market cap).
- •Both run net losses; CNTX's is the smaller (0.00% vs -12.24% net margin).
Metrics side by side
Valuation
| Metric | ARAY | CNTX |
|---|---|---|
| P/S ratio | 0.09 | N/A |
| P/B ratio | 0.86 | 0.81 |
Profitability
| Metric | ARAY | CNTX |
|---|---|---|
| Gross margin | 27.73% | 0.00% |
| Operating margin | -6.58% | 0.00% |
| Net margin | -12.24% | 0.00% |
| ROE | -117.97% | -120.40% |
| ROIC | -10.09% | -126.84% |
Growth (annualized)
| Metric | ARAY | CNTX |
|---|---|---|
| Revenue CAGR (5Y) | 0.28% | N/A |
| Total return CAGR (5Y) | -39.94% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.